Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. Earnings in 48 days. Avg 30D Vol at 24.67M Current Vol at 74.70M
Can this break and retest $2.35? If it does analyst have targets as high as $10. GL!
Can this break and retest $2.35? If it does analyst have targets as high as $10. GL!
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。